Champions Oncology, Inc. (CSBR)
Company Info
Highlights
$151.65M
-$0.05
$41.55M
$20.16M
$3.53M
$3.60 - $11.99
$8.00
1.86%
1.73
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Champions Oncology, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Champions Oncology, Inc. had a return of 29.17% year-to-date (YTD) and 91.54% in the last 12 months. Over the past 10 years, Champions Oncology, Inc. had an annualized return of 11.11%, which was very close to the S&P 500 benchmark's annualized return of 11.26%.
CSBR
29.17%
13.19%
142.22%
91.54%
8.91%
11.11%
^GSPC (Benchmark)
3.96%
1.97%
9.03%
22.16%
12.60%
11.26%
Monthly Returns
The table below presents the monthly returns of CSBR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 28.24% | 29.17% | |||||||||||
| 2024 | 3.38% | 1.55% | -16.95% | -1.02% | -6.60% | 14.13% | -7.35% | -11.90% | 15.40% | -19.71% | 15.60% | 89.60% | 52.49% |
| 2023 | -8.87% | 13.14% | -13.55% | 22.39% | 5.89% | 22.46% | 1.88% | 3.08% | -7.31% | -12.08% | -5.68% | 9.12% | 24.61% |
| 2022 | -4.07% | -2.12% | 3.57% | -5.54% | -3.65% | 8.11% | 8.25% | -7.85% | -6.02% | -7.47% | -0.58% | -34.64% | -46.05% |
| 2021 | 1.76% | 6.38% | -3.25% | -5.04% | -12.30% | 9.25% | 1.65% | -7.27% | 5.37% | -4.31% | -18.94% | 5.56% | -22.52% |
| 2020 | -8.88% | -17.00% | 17.46% | 4.32% | 24.74% | -0.73% | -8.58% | -5.26% | 11.71% | -5.08% | 29.50% | -5.10% | 29.53% |
| 2019 | 56.59% | -4.99% | -15.75% | -7.25% | 3.08% | -16.35% | -17.37% | -16.54% | 4.63% | -7.43% | 10.13% | 44.62% | 6.66% |
| 2018 | -1.55% | -9.16% | 4.90% | 19.10% | 6.80% | 36.93% | 26.18% | 10.25% | 98.07% | -29.14% | 2.34% | -38.36% | 101.29% |
| 2017 | 87.75% | -27.37% | -8.12% | -16.40% | -9.06% | 6.64% | 10.51% | 6.69% | 21.12% | -12.81% | 12.19% | 8.08% | 53.36% |
| 2016 | 1.40% | 0.83% | -0.26% | 5.75% | -14.03% | -35.05% | -8.84% | -18.88% | 5.66% | -5.95% | 39.24% | 15.00% | -29.13% |
| 2015 | -9.98% | -28.91% | 118.82% | -12.86% | -9.84% | -9.09% | -3.98% | 9.18% | -14.94% | 2.06% | -16.67% | -21.54% | -40.49% |
| 2014 | -16.67% | 18.00% | -16.10% | -8.08% | 4.40% | 5.26% | -11.00% | -12.36% | -5.13% | -5.41% | -8.57% | -21.89% | -58.34% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 79, CSBR is among the top 21% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Champions Oncology, Inc. (CSBR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Champions Oncology, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Champions Oncology, Inc. was 94.13%, occurring on Sep 16, 2016. The portfolio has not yet recovered.
The current Champions Oncology, Inc. drawdown is 56.07%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.13% | Oct 25, 2007 | 1575 | Sep 16, 2016 | — | — | — |
| -88.5% | Feb 21, 2006 | 56 | Oct 24, 2006 | 24 | Jan 10, 2007 | 80 |
| -71.43% | Sep 13, 2004 | 14 | Oct 25, 2004 | 96 | Nov 11, 2005 | 110 |
| -70% | Feb 18, 2003 | 2 | Feb 20, 2003 | 16 | Apr 28, 2003 | 18 |
| -70% | Feb 17, 2004 | 7 | Mar 11, 2004 | 10 | Apr 15, 2004 | 17 |
Volatility
Volatility Chart
The current Champions Oncology, Inc. volatility is 22.40%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Champions Oncology, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |